The first critical care monitoring device to achieve FDA Breakthrough Designation for the diagnosis of electrographic status epilepticus with an exclusive New Technology Add-on Payment (NTAP) from CMS

ClarityPro is a machine learning algorithm that interprets EEG signals and provides alerts when continuous seizures indicating status epilepticus are detected.

At the bedside, ClarityPro delivers 24/7 bedside EEG monitoring and alerts:

Ceribell seizure burden display

The first FDA-cleared instantaneous bedside alert diagnosing electrographic status epilepticus

Continuous EEG monitoring and seizure burden display

Remotely, ClarityPro provides:

The first FDA-cleared seizure burden trend with pre-annotations to support efficient EEG interpretation

Accurate EEG seizure burden labeling

Real-time medication effectiveness

Easily annotate medications at the bedside with just a touch

Intuitive medication response monitoring for treatment optimization in real-time

How Does ClarityPro Work?*

Clarity is a machine-learning, cloud-based AI algorithm that interprets the EEG every 10 seconds across all EEG channels to provide a seizure burden estimate.

Seizure burden is the amount of seizure activity detected in the prior 5-minute window. Prolonged seizures, such as status epilepticus, which is associated with poor neurological outcomes, display a high seizure burden.

Clarity AI is designed to provide clinically meaningful information

  • Automatically detect suspected non-convulsive status epilepticus at the bedside
  • Diagnose electrographic status epilepticus with Clarity Plus
  • Continuously monitor the EEG for ongoing seizure burden
  • Trained on thousands of EEG annotated by epileptology experts and continuously improving
  • Clinically proven to detect or rule out status epilepticus at the case-level

Practical Considerations

  • EEG offers one component of diagnostic insight. The decision to administer treatment, or not, should consider the combination of clinical history, patient presentation, and objective data.
  • Inter-rater variability of EEG diagnoses is well-documented among expert readers. Since ClarityPro AI is trained based on expert input, a degree of inter-rater variability between Clarity AI’s output and the interpretation of the same case by a skilled neurologist should be expected.
  • The capability and accuracy of the ClarityPro AI continues to improve with increased training on a growing volume of cases.
  • ClarityPro AI is designed as an acute care tool to measure the overall burden of seizures, rather than detailed labeling of each individual epileptiform event, since the cumulative impact of seizure activity has greater impact on acute patient management and prognosis.

*Kamousi, B., et al. (2022) American Epilepsy Society Abstract 1.475

Studies show that Clarity is highly accurate

360 N Pastoria Avenue
Sunnyvale, CA 94085, USA

Contact Us:

Technical Support: 1.800.763.0183

General Inquiries: 1.800.436.0826

Caution: Federal (US) law restricts Ceribell devices to sale by or on the order of a physician. Ceribell devices are intended to be used by trained healthcare providers in a professional healthcare facility environment. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

© 2023 Ceribell, Inc. All Rights Reserved           MK-00002, rev AK